Status:
COMPLETED
Failure to Adjuvant Therapy After Pancreatic Resection for Pancreatic Cancer
Lead Sponsor:
Universita di Verona
Conditions:
Pancreatic Malignant Neoplasm Primary
Eligibility:
All Genders
18+ years
Brief Summary
This study aims to evaluate the rate of patients submitted to pancreatic resection for pancreatic cancer, who fail to access to adjuvant therapy or do not complete adjuvant therapy. The purpose is to ...
Detailed Description
This prospective observational study will evaluate all patients submitted to pancreatic resection for pancreatic cancer. The rate of omission to adjuvant therapy and rate of failure of completion of ...
Eligibility Criteria
Inclusion
- Histologic diagnosis of pancreatic cancer
Exclusion
- Non exocrine pancreatic tumors
- Periampullary malignancies
Key Trial Info
Start Date :
January 1 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 28 2024
Estimated Enrollment :
317 Patients enrolled
Trial Details
Trial ID
NCT03788382
Start Date
January 1 2019
End Date
February 28 2024
Last Update
May 7 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Verona Hospital
Verona, Italy, 37134